Bio-Rad Laboratories
(BIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 456,264 | 417,939 | 418,651 | 403,615 | 457,549 |
| Marketable Securities | 387,736 | 392,387 | 377,154 | 349,255 | 332,928 |
| Receivables | 372,348 | 367,662 | 366,281 | 381,100 | 391,485 |
| Inventories | 524,961 | 556,358 | 541,514 | 533,312 | 490,224 |
| Other current assets | 12,201 | 115,757 | 102,088 | 107,982 | 11,041 |
| TOTAL | $1,844,524 | $1,850,103 | $1,805,688 | $1,775,264 | $1,777,596 |
| Non-Current Assets | |||||
| PPE Net | 488,614 | 474,667 | 457,685 | 449,226 | 437,690 |
| Investments And Advances | 830,790 | 903,658 | 810,463 | 711,437 | 719,840 |
| Intangibles | 638,724 | 727,477 | 736,020 | 751,846 | 709,974 |
| Other Non-Current Assets | 47,852 | 63,821 | 64,779 | 65,640 | 64,618 |
| TOTAL | $2,005,980 | $2,169,623 | $2,068,947 | $1,978,149 | $1,932,122 |
| Total Assets | $3,850,504 | $4,019,726 | $3,874,635 | $3,753,413 | $3,709,718 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 297 | 294 | 296 | N/A |
| Accounts payable and accrued liabilities | 133,109 | 280,453 | 256,112 | 0 | 122,391 |
| Accrued Expenses | 163,364 | N/A | N/A | 241,249 | 157,857 |
| Other current liabilities | 115,388 | 139,694 | 132,143 | 131,618 | 101,783 |
| TOTAL | $471,322 | $442,718 | $410,405 | $400,888 | $441,351 |
| Non-Current Liabilities | |||||
| Long Term Debt | 434,186 | 434,137 | 434,057 | 433,980 | 433,883 |
| Deferred Revenues | 31,003 | N/A | N/A | N/A | 29,683 |
| Other Non-Current Liabilities | 140,537 | 140,535 | 415,612 | 374,096 | 110,506 |
| TOTAL | $800,022 | $874,317 | $849,669 | $808,076 | $777,864 |
| Total Liabilities | $1,271,344 | $1,317,035 | $1,260,074 | $1,208,964 | $1,219,215 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,577 | 29,541 | 29,423 | 29,397 | 29,362 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | 1,828,581 | 1,856,750 | 1,838,345 | 1,820,331 | 1,808,055 |
| Other shareholders' equity | 417,665 | 521,302 | 459,459 | 415,239 | 382,037 |
| TOTAL | $2,579,160 | $2,702,691 | $2,614,561 | $2,544,449 | $2,490,503 |
| Total Liabilities And Equity | $3,850,504 | $4,019,726 | $3,874,635 | $3,753,413 | $3,709,718 |